Skip to main content
. Author manuscript; available in PMC: 2019 Feb 8.
Published in final edited form as: J Neuromuscul Dis. 2018;5(4):481–495. doi: 10.3233/JND-180306

Table 2.

Selected demographics for MD STARnet case classifications and phenotype assignments

All Cases
No phenotype assigned
DMD
BMD
P*
Total N % N % N % N %
987 100% 28 100% 838 100% 121 100%
State 0.40
 Arizona 229 23% 6 22% 199 24% 24 20%
 Colorado 214 22% 7 25% 184 22% 23 19%
 Georgia 272 28% 3 11% 233 28% 36 30%
 Hawaii 23 3% - 22 3% 1 1%
 Iowa 124 12% 3 11% 104 12% 17 14%
 New York 125 12% 9 32% 96 12% 20 17%
Race/Ethnicity 0.02
 Non-Hispanic White 576 58% 18 64% 482 58% 76 635
 Hispanic, Any Race 200 20% 4 14% 182 22% 14 12%
 Non-Hispanic Black 68 8% 3 10% 57 7% 8 7%
 Other 61 6% 1 4% 54 6% 6 5%
 Unknown 82 8% 2 8% 63 8% 17 14%
MD STARnet Classification 0.01
 Definite 820 83% 26 93% 693 83% 101 83%
 Probable 65 7% 2 7% 57 7% 6 5%
 Possible 94 10% - 84 10% 10 8%
 Asymptomatic 8 1% - 4 0% 4 3%
Level of Certainty 0.01
 High (3 variables) 248 25% - 232 28% 16 13%
 Med (2 variables) 446 45% - 402 48% 44 37%
 Low (1 variable) 265 27% - 204 24% 61 50%
Molecular Index Variable
 DMD 589 60% 18 65% 549 66% 22 18% 0.00
 BMD 134 13% 8 28% 55 7% 71 59%
 Inconclusive 1 0% - 1 0% 0 0%
 Missing 263 27% - - -
Mobility Index Variable
 DMD 525 53% 1 0% 524 63% 01 0% 0.37
 BMD 90 9% 18 64% 1 0% 71 59%
 Inconclusive 327 33% 8 29% 277 33% 42 35%
 Missing 45 5% - - -
Onset Index Variable
 DMD 627 63% 22 79% 588 70% 17 14% 0.00
 BMD 41 4% 1 3% 4 0% 36 30%
 Inconclusive 254 26% 5 18% 204 24% 45 37%
 Missing 65 7% - - -

MD STARnet: Muscular Dystrophy Surveillance Tracking and Research Network; BMD: Becker muscular dystrophy; DMD: Duchenne muscular dystrophy.

*

Only predictive and non-predictive for BMD vs DMD were included in chi-square analyses. Non-predictive included wrong phenotype and inconclusive.

Cells contributing to chi-square differences with a standardized residual ≥|2.0|